Skip to main content
    C

    CME Group Inc (CME)

    Official site

    FINANCIAL SERVICES • FINANCIAL DATA & STOCK EXCHANGES • NASDAQ

    $305.71
    -0.27 (-0.09%)

    Market Cap: $109.42B

    Last updated: Oct 27, 2026 at 10:41 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    88%(35/40)
    Avg Surprise
    +1.88%
    Streak
    2 Q

    Upcoming Estimates

    Period ending Dec 31, 2026
    EPS Consensus$3.16
    Range$3.07 - $3.39
    13 analysts
    Revenue Consensus
    $1.8B
    Range$1.7B - $1.9B
    12 analysts
    Period ending Mar 31, 2027
    EPS Consensus$3.32
    Range$3.07 - $3.60
    12 analysts
    EPS Revisions
    1
    0
    7d
    3
    4
    30d
    EPS Estimate DriftChange to current
    90d ago$3.29+1.2%
    60d ago$3.29+1.2%
    30d ago$3.28+1.3%
    7d ago$3.30+0.6%
    Current$3.32
    Revenue Consensus
    $1.9B
    Range$1.7B - $2.0B
    8 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Mar 27EST
    -$3.32---
    Dec 26EST
    -$3.16---
    Sep 26
    Reported Oct 21
    $3.02$2.98+1.34%Beat+12.7%
    Jun 26
    Reported Jul 22
    $2.99$2.91+2.75%Beat+1.0%
    Mar 26
    Reported Apr 22
    $3.36$3.37-0.30%Miss+20.0%
    Dec 25
    Reported Feb 4
    $2.77$2.74+1.09%Beat+9.9%
    Sep 25
    Reported Oct 22
    $2.68$2.63+1.90%Beat+0.0%
    Jun 25
    Reported Jul 23
    $2.96$2.92+1.37%Beat+15.6%
    Mar 25
    Reported Apr 23
    $2.80$2.81-0.36%Miss+12.0%
    Dec 24
    Reported Feb 12
    $2.52$2.45+3.05%Beat+6.3%
    Sep 24
    Reported Oct 23
    $2.68$2.65+1.13%Beat+19.1%
    Jun 24
    Reported Jul 24
    $2.56$2.53+1.19%Beat+11.3%
    Mar 24
    Reported Apr 24
    $2.50$2.45+2.04%Beat+3.3%
    Dec 23
    Reported Feb 14
    $2.37$2.28+3.95%Beat+23.4%
    Sep 23
    Reported Oct 25
    $2.25$2.22+1.35%Beat+13.6%
    Jun 23
    Reported Jul 26
    $2.30$2.19+5.02%Beat+16.8%
    Mar 23
    Reported Apr 26
    $2.42$2.38+1.68%Beat+14.7%
    Dec 22
    Reported Feb 8
    $1.92$1.88+2.13%Beat+15.7%
    Sep 22
    Reported Oct 26
    $1.98$1.94+2.06%Beat+23.7%
    Jun 22
    Reported Jul 27
    $1.97$1.93+2.07%Beat+20.1%
    Mar 22
    Reported Apr 27
    $2.11$2.00+5.50%Beat+17.9%
    Dec 21
    Reported Feb 9
    $1.66$1.64+1.22%Beat+19.4%
    Sep 21
    Reported Oct 27
    $1.60$1.55+3.23%Beat+15.9%
    Jun 21
    Reported Jul 28
    $1.64$1.61+1.86%Beat+0.6%
    Mar 21
    Reported Apr 28
    $1.79$1.76+1.70%Beat-23.2%
    Dec 20
    Reported Feb 10
    $1.39$1.36+2.21%Beat-8.6%
    Sep 20
    Reported Oct 28
    $1.38$1.44-4.17%Miss-27.4%
    Jun 20
    Reported Jul 29
    $1.63$1.64-0.61%Miss-7.4%
    Mar 20
    Reported Apr 29
    $2.33$2.21+5.43%Beat+43.8%
    Dec 19
    Reported Feb 12
    $1.52$1.55-1.94%Miss-14.1%
    Sep 19
    Reported Oct 30
    $1.90$1.75+8.57%Beat+31.0%
    Jun 19
    Reported Jul 31
    $1.76$1.76+0.00%Beat+1.1%
    Mar 19
    Reported May 1
    $1.62$1.60+1.25%Beat-12.9%
    Dec 18
    Reported Feb 14
    $1.77$1.72+2.91%Beat+58.0%
    Sep 18
    Reported Oct 25
    $1.45$1.43+1.40%Beat+21.8%
    Jun 18
    Reported Jul 26
    $1.74$1.72+1.16%Beat+41.5%
    Mar 18
    Reported Apr 26
    $1.86$1.85+0.54%Beat+52.5%
    Dec 17
    Reported Feb 1
    $1.12$1.10+1.82%Beat-1.8%
    Sep 17
    Reported Oct 26
    $1.19$1.16+2.59%Beat-
    Jun 17
    Reported Aug 1
    $1.23$1.21+1.65%Beat-
    Mar 17
    Reported Apr 27
    $1.22$1.20+1.67%Beat-
    Dec 16
    Reported Feb 2
    $1.14$1.10+3.64%Beat-

    Dividends

    Dividend Metrics

    Forward Yield1.70%
    Forward Annual Dividend$5.20
    Payout Ratio31.14%
    FrequencyQuarterly
    Pay MonthsMar, Jun, Sep, Dec

    Growth

    3Y CAGR+7.72%
    5Y CAGR+8.02%

    Key Metrics

    Valuation
    P/E Ratio25.18EV/EBITDAN/A
    Price/FCF25.26xFCF Yield3.96%
    Profitability
    Profit Margin63.50%Operating Margin65.70%
    ROE16.10%ROIC-1.17%
    Financial Health
    Debt/Equity0.13xInterest Coverage1.69x
    Current Ratio1.02xQuick Ratio1.02x
    Trading Statistics
    Beta0.27Avg Volume2.05M
    52-Week High$318.3252-Week Low$217.29

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$292.05
    SMA 20$280.23
    SMA 50$276.93
    SMA 200$276.58
    EMA 10$293.49
    EMA 20$285.88
    EMA 50$277.01
    EMA 200$271.62

    MACD

    Line: 8.24Signal: 5.20Hist: 3.04

    ADX

    ADX: 30.9+DI: 37.9-DI: 12.1

    Aroon & PSAR

    Aroon Up100.0
    Aroon Down20.0
    PSAR$291.74

    Bollinger Bands

    Upper Band$309.34
    Lower Band$251.13
    %B Position2077%(Upper)
    Band Width0.94

    RSI (14-Day)

    Overbought
    78.0

    Momentum Oscillators

    Stoch %K93.9
    Stoch %D92.6
    Williams %R-5.1
    ROC (10d)9.0%
    Momentum25.15
    CCI (20d)144.3
    MFI (14d)84.1

    Volatility Measures

    ATR (14d)$6.22(2.0%)
    StdDev (20d)14.55
    Hist Vol20.3%(Moderate)

    Volume Flow

    VWAP$305.81
    OBV44.9M
    AD Line-2.0B
    CMF (20d)0.217

    Volume Metrics

    Avg Vol (20d)2.1M
    Vol Ratio1.0x
    VWMA (20d)$282.48

    Pivot Points

    R3$317.10
    R2$312.19
    R1$309.08
    Pivot Point$304.17
    S1$301.06
    S2$296.15
    S3$293.04

    Advanced Oscillators

    TSI37.63
    Ultimate Osc67.0
    KST60.86

    Financial Data

    QuarterSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total Revenue$1.74B$1.71B$1.88B$1.65B$1.54B$1.69B$1.64B$1.53B$1.58B$1.53B$1.49B$1.44B
    Cost of Revenue$234.30M$233.50M$223.00M$241.10M$237.60M$221.60M$206.70M$220.80M$218.80M$204.70M$206.00M$212.90M
    Gross Profit$1.50B$1.47B$1.66B$1.41B$1.30B$1.47B$1.44B$1.30B$1.37B$1.33B$1.28B$1.23B
    Operating Expenses$361.60M$365.60M$347.40M$388.00M$327.40M$341.10M$327.60M$357.40M$341.40M$327.20M$322.30M$363.20M
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$93.10M$89.00M$80.70M$133.80M$91.80M$90.60M$82.80M$124.30M$93.30M$93.00M$89.70M$138.00M
    Operating Income$1.14B$1.11B$1.31B$1.02B$972.60M$1.13B$1.11B$947.10M$1.02B$1.00B$959.60M$863.20M
    Interest Income$1.52B$1.53B$1.49B$1.86B$1.65B$1.62B$980.90M$1.03B$1.11B$1.13B$1.16B$1.14B
    Interest Expense$43.50M$43.60M$43.60M$43.70M$44.00M$44.00M$41.70M$40.70M$40.20M$40.10M$39.90M$39.70M
    Income Before Tax$1.35B$1.33B$1.51B$1.58B$1.18B$1.33B$1.24B$1.10B$1.18B$1.15B$1.11B$1.01B
    Income Tax Expense$317.90M$285.90M$356.60M$395.50M$269.00M$305.20M$288.60M$222.00M$264.10M$271.30M$258.20M$191.40M
    Net Income$1.04B$1.04B$1.15B$1.18B$908.00M$1.03B$956.20M$874.60M$912.80M$883.20M$855.20M$814.60M
    EBITDA$-39,200,000$-71,900,000$146.10M$-160,400,000$-341,400,000$-159,700,000$388.10M$193.00M$188.10M$147.90M$80.10M$-11,700,000
    EBIT$-122,600,000$-156,100,000$62.80M$-242,800,000$-424,000,000$-243,100,000$305.60M$109.60M$104.20M$63.70M$-5,200,000$-98,000,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    Follow The Money And The Meter: Our Midterm Playbook For The Tech Trade

    Democratic majorities gain oversight and funding levers - vetoes and the filibuster make sweeping legislation unlikely without White House cooperation Mid-Oct odds: Kalshi 90% House...

    Leo Nelissen
    •
    10/27/26
    •
    74
    AI Infrastructure, Data Centers, Power Infrastructure, hyperscalers
    Also mentions:
    AZNLLYPFEAMZNGOOGL

    The Never-Sell Test: Which Stocks Actually Deserve Forever

    Never-sell advantages - uninterrupted compounding, deferred taxes (unrealized gains act as an interest-free loan), and fewer behavioral mistakes from reduced trading decisions Selling math example - if 50% of a $100 position is unrealized gain you pay $13.19 tax, reinvest $86.81...

    Leo Nelissen
    •
    10/8/26
    •
    296
    Investing Strategy
    Also mentions:
    AAPLAMAMZNBRK.BCAT

    The Fed Can't Print Oil: How Inflation Really Works, And What We Want To Own Before The Midterms

    Core thesis - most money is created by bank lending, deposits arise when loans are made, so money supply often reacts to credit demand rather than driving prices unilaterally FOMC hiked 25bp on Sep 16 to a 3.75%-4.00% target in a 12-0 vote...

    Leo Nelissen
    •
    10/5/26
    •
    204
    Federal Reserve, Macro Strategy
    Also mentions:
    CMECNQDTMLBMPLX

    We're Preparing For A 30-Year Debasement Cycle

    Debasement cycle since 2020 has failed to lower debt/GDP - six years in the ratio is higher, risking a stalled cycle that could stretch 22-35 years or produce $9,000 gold within six years Fiscal trajectory - CBO projects 2026 deficit 5.8% of GDP, primary deficit 2.6%...

    Leo Nelissen
    •
    10/2/26
    •
    256
    Gold, Macro Strategy
    Also mentions:
    IAUIGLDFNVWPMRGLD

    The Best Portfolio Of The Last 54 Years Is Built For The Wrong Regime

    Maggiulli's 1972-2025 optimal mix: 36% US homes, 27% S&P500, 18% gold, 16% 10yr Treasuries, 3% REITs, delivering 4.5% real annual return, max drawdown ~13% Three weights - Treasuries, US homes, gold...

    Leo Nelissen
    •
    9/30/26
    •
    181
    Investing Strategy
    Also mentions:
    UNPCPODFLGETDG

    News

    CME Valuation and Fair Value

    P/E
    25.2x
    Forward P/E
    22.3x
    P/FCF
    25.3x
    PEG
    4.8x
    P/B
    4.1x
    See GNG's fair value

    CME Profitability: Margins, ROIC and FCF

    Gross margin
    86.6%
    Operating margin
    65.7%
    Net margin
    63.5%
    ROIC
    -1.2%
    ROE
    16.1%
    FCF margin
    62.1%
    FCF yield
    4.0%

    CME Analyst Ratings

    Consensus
    Hold
    Analysts
    16
    Strong Buy
    5
    Buy
    3
    Hold
    5
    Sell
    1
    Strong Sell
    2

    CME Bull Case vs Bear Case

    Bull case

    • CME converts 62.1% of revenue into free cash flow.
    • CME has a 63.5% net profit margin.
    • CME beat EPS estimates in 75.0% of its last 8 reported quarters.

    CME Earnings: Beat Rate and Next Report

    Beat rate
    6 of 8 quarters (75.0%)
    Average surprise
    1.4%
    EPS estimate (fiscal period ending Dec 31, 2026)
    $3.16

    CME Dividend

    Forward yield
    1.7%
    Payout ratio
    31.1%
    3Y DPS growth
    7.7%
    5Y DPS growth
    8.0%
    Pay months
    Mar, Jun, Sep, Dec
    CME dividend history

    Frequently Asked Questions About CME

    What is CME's current dividend yield?

    CME Group Inc (CME) has a forward dividend yield of 1.70%.

    Does CME pay dividends?

    Yes, CME Group Inc pays dividends with a forward dividend yield of 1.70%.

    What is CME's P/E ratio?

    CME Group Inc has a price-to-earnings (P/E) ratio of 25.18.

    What is CME's market cap?

    CME Group Inc (CME) has a market capitalization of $109.42B with a current stock price of $305.71.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.